The nation of Zimbabwe has declined a substantial American healthcare agreement worth 367 million US dollars (272 million pounds) spanning five years because of the United States' demand for confidential information.
This move was revealed after a internal memorandum dated December was disclosed, indicating that Head of State Emmerson Mnangagwa believed the arrangement was "lopsided".
An official representative later explained that the US was seeking health data for research and commercial purposes while refused to guarantee the resulting advantages from future medical innovations.
"We must now begin the challenging and unfortunate task of ending our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had donated more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has called for further dialogue to find a deal suitable to all parties so the country's vital HIV treatment initiative can be sustained.
Wider Context
Zimbabwe's decision follows a similar case in Kenya, where a court blocked a related health funding agreement following concerns were filed about the security of Kenyans' medical information.
After resuming the presidency last year, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.
USAID had managed assistance for the US government, but Trump claimed its spending was "wasteful" and his government was pursuing direct bilateral agreements to enhance openness and responsibility.
Based on reports, 16 African countries have so far agreed to these new agreements, representing over $18.3bn in committed funds.
Details of the Rejected Agreement
The funds for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this partnership might have yielded extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving HIV treatment through American-funded initiatives," Tremont commented.
However, official spokesman Nick Mangwana maintained the arrangement was "unfair".
"Our nation was requested to provide its genetic material and health information indefinitely, with no corresponding promise of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that provided information," his statement read.
"Put simply, our country would supply the raw materials for scientific discovery with no certainty that the final treatments would be accessible to our people if a future pandemic arise."
Sovereignty and Global Health
He also pointed out that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were undermining structures already established through the international health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework designed to manage future global health emergencies.
"This framework is intended to guarantee that when a country contributes its data, the benefits – including medicines and cures – are distributed fairly, not commercialised exclusively by those with the capability to create them."
The government's concerns over the US deal "are not meant as anti-American sentiment," he added.
"We are open to further discussions with our US partners on how subsequent co-operation could be arranged in a manner that honours the independence and interests of both nations."
Health Experts Response
Medical experts stated it understood the government's concerns, but recommended that talks need to persist since a large portion of the country's Aids initiatives depended on international support.
"If technical issues exist, including those relating to data governance or agreement terms, these can often be resolved through detailed discussion and mutually agreed protections," the group said.
The halted deal emphasises the continuing debate between accepting vital international aid and protecting national sovereignty in an ever more data-driven world.